Ampio Pharmaceuticals
AMPE
#11313
Rank
HK$1.63 M
Marketcap
HK$1.44
Share price
0.00%
Change (1 day)
1,748.41%
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$133.67. In 2022 the company made an earnings per share (EPS) of -HK$170.06 an increase over its 2021 EPS that were of -HK$211.80.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-21.38%
2022-HK$170.06-19.7%
2021-HK$211.80-0%
2020-HK$211.80-10%
2019-HK$235.33-121.74%
2018HK$1,083-158.23%
2017-HK$1,859119.44%
2016-HK$847.18-41.94%
2015-HK$1,459-18.42%
2014-HK$1,78920.63%
2013-HK$1,48385.29%
2012-HK$800.12-52.11%
2011-HK$1,67144.9%
2010-HK$1,153390%
2009-HK$235.33233.33%
2008-HK$70.60-0%
2007-HK$70.60
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51-151.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.96-104.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$24.46-118.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$328.75-345.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$138.61-203.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.88-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA